Speaker:
Natalie Schmitz, MPA, PHarmD, PhD, Assistant Professor - Pharmacy Practice Division, UW-Madison School of Pharmacy
Learning Objectives:
- Describe the endocannabinoid system and major cannabinoid compounds
- Explain legal status of cannabinoids
- Discuss potential therapeutic applications, adverse effects, and drug-drug interactions
- Identify the impact of different formulations and routes of administration
- Identify important considerations for cannabinoid product selection
Credit Designation Statement
American Board of Pediatrics
Successful completion of this CME activity, which included participation in the activity, with individual assessment of the participant and feedback to the participant, enables the participant to earn 1.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Session date:
12/12/2019 - 7:30am to 8:30am CST
Location:
Health Sciences Learning Center
750 Highland Avenue
Room 1345
Madison, WI
53792
United States
See map: Google Maps
- 1.00 MOC: ABP Lifelong Learning Points (Part II)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar:
Discloser List CME Internal Report
Presenter(s):
Natalie Schmitz, MPA, PharmD, PhD